S20 Nuclear Receptors in Energy Homeostasis

Program: Symposia
Basic Session
Friday, April 1, 2016: 4:45 PM-6:15 PM
Room 107 (BCEC)
Chair:
Franck Mauvais-Jarvis, MD, PhD, Tulane University Health Sciences Center, New Orleans, LA

Disclosures:
FM: Investigator, Pfizer, Inc..
4:45 PM
Karen Ryan, PhD, Neurobiology, Physiology and Behavior, University of California-Davis, Davis, CA
Nothing to Disclose: KR
5:15 PM
Miguel López, PhD, Center for Research on Molecular Medicine and Chronic Diseases, University of Santiago de Compostela, Santiago de Compostela, Spain
Nothing to Disclose: ML
5:45 PM
Yong Xu, PhD, Pediatrics, Baylor College of Medicine, Houston, TX
Nothing to Disclose: YX
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire